Livzon Pharmaceutical Group (SZSE:000513) YoY EBITDA Growth : 14.73% (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Livzon Pharmaceutical Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 14.73%.

Livzon Pharmaceutical Group's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.93.

Livzon Pharmaceutical Group YoY EBITDA Growth Historical Data

The historical data trend for Livzon Pharmaceutical Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group YoY EBITDA Growth Chart

Livzon Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

17.33

37.28

-4.35

10.85

8.60

Livzon Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															1.38	15.67	1.82	-9.71	14.73

Livzon Pharmaceutical Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Livzon Pharmaceutical Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(3.574	-	3.291)	/	\| 3.291 \|
=	8.60 %

Livzon Pharmaceutical Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.927	-	0.808)	/	\| 0.808 \|
=	14.73 %

Livzon Pharmaceutical Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Livzon Pharmaceutical Group (SZSE:000513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

01513:Hong Kong LP6:Germany

Address

38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090

Website

https://www.livzon.com.cn

Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Executives

Xu Guo Xiang	Directors, executives
Tang Yang Gang	Directors, executives
Yang Liang	Secretary Dong
Si Yan Xia	Executives
Zhou Peng	Executives
Huang Yu Xuan	Executives
Huang Hua Min	Supervisors
Yang Dai Hong	Executives
Wang Wu Ping	Executives

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines